1. Home
  2. AIMD vs KXIN Comparison

AIMD vs KXIN Comparison

Compare AIMD & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • KXIN
  • Stock Information
  • Founded
  • AIMD 1984
  • KXIN 2015
  • Country
  • AIMD United States
  • KXIN China
  • Employees
  • AIMD N/A
  • KXIN N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • AIMD Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • AIMD Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • AIMD 11.9M
  • KXIN 10.4M
  • IPO Year
  • AIMD N/A
  • KXIN N/A
  • Fundamental
  • Price
  • AIMD $2.33
  • KXIN $0.78
  • Analyst Decision
  • AIMD
  • KXIN
  • Analyst Count
  • AIMD 0
  • KXIN 0
  • Target Price
  • AIMD N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • AIMD 134.7K
  • KXIN 139.7K
  • Earning Date
  • AIMD 08-15-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • AIMD N/A
  • KXIN N/A
  • EPS Growth
  • AIMD N/A
  • KXIN N/A
  • EPS
  • AIMD N/A
  • KXIN N/A
  • Revenue
  • AIMD $106,207.00
  • KXIN N/A
  • Revenue This Year
  • AIMD N/A
  • KXIN N/A
  • Revenue Next Year
  • AIMD N/A
  • KXIN N/A
  • P/E Ratio
  • AIMD N/A
  • KXIN N/A
  • Revenue Growth
  • AIMD 13.38
  • KXIN N/A
  • 52 Week Low
  • AIMD $2.00
  • KXIN $0.64
  • 52 Week High
  • AIMD $5.00
  • KXIN $29.54
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 36.64
  • KXIN 37.41
  • Support Level
  • AIMD $2.40
  • KXIN $0.70
  • Resistance Level
  • AIMD $2.66
  • KXIN $0.85
  • Average True Range (ATR)
  • AIMD 0.19
  • KXIN 0.06
  • MACD
  • AIMD -0.04
  • KXIN -0.01
  • Stochastic Oscillator
  • AIMD 11.77
  • KXIN 29.37

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: